Skip to main content

Published locations for Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCL

User login

  • Reset your password
  • /content/study-halted-hyperprogression-seen-nivolumab-r/r-ptcl
  • /fedprac/article/213814/t-cell-lymphomas/study-halted-hyperprogression-seen-nivolumab-r/r-ptcl
  • /hematologynews/article/213814/t-cell-lymphomas/study-halted-hyperprogression-seen-nivolumab-r/r-ptcl
  • /internalmedicinenews/article/213814/t-cell-lymphomas/study-halted-hyperprogression-seen-nivolumab-r
  • /oncologypractice/article/213814/t-cell-lymphomas/study-halted-hyperprogression-seen-nivolumab-r/r
  • /fedprac/avaho/article/213814/t-cell-lymphomas/study-halted-hyperprogression-seen-nivolumab-r/r-ptcl
  • /hematology-oncology/article/213814/t-cell-lymphomas/study-halted-hyperprogression-seen-nivolumab-r/r
  • /hematologytimes/article/213814/t-cell-lymphomas/study-halted-hyperprogression-seen-nivolumab-r/r
  • /internalmedicine/article/213814/t-cell-lymphomas/study-halted-hyperprogression-seen-nivolumab-r/r